This story has been updated from a previous version to include comments made during Bio-Rad's earnings call.
NEW YORK (GenomeWeb) – Bio-Rad reported after the close of the market on Thursday that its second quarter revenues fell 2 percent on both a reported and currency-neutral basis.
For the three months ended June 30, Bio-Rad reported $504.7 million in net sales compared to $516.8 million in the year-ago quarter and short of analysts' average estimate of $515.9 million.